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Abstract
Background: Glycemic control in diabetes mellitus is a cornerstone in reducing morbidity and mortality of the
disease. Achieving glycemic control or reducing hyperglycemia significantly decreases the microvascular and
macrovascular complications of diabetes. Even though measurement of glycated hemoglobin (HbA1c) remains the
gold standard for assessment of glycemic control, there is no consensus whether fasting or postprandial plasma
glucose (PPG) is a better predictor of glycemic control in resource-poor settings when HbA1c is not available. The
aim of this systematic review and meta-analysis was to summarize evidences on the significance of fasting and
postprandial plasma glucose, and their correlation with HbA1c.
Methods: Relevant studies were identified through systematic search of online databases (e.g. EMBASE, MEDLINE/
PubMed and Cochrane library) and manual search of bibliographies of the included studies. Original research
papers describing the correlations or associations of fasting and postprandial plasma glucose with HbA1c were
included. The MedCalc software was used for data entry and analysis. We used the random effect model to
estimate the pooled correlations of fasting and postprandial plasma glucose with HbA1c. Heterogeneity assessment
and robustness analysis was also performed.
Result: From total 126 articles identified, 14 articles were eligible for systemic review. Eleven of these eligible
studies evaluated the correlations of fasting and postprandial plasma glucose to the standard HbA1c values and
used in meta-analysis. Seven of these studies (63.5 %) found better or stronger correlations between PPG and
HbA1c than fasting plasma glucose (FPG). In all the studies that estimated the relative contribution FPG and PPG to
the overall hyperglycemia, decreases in PPG was accounted for greater decrease in HbA1c compared with
decreases in FPG value. PPG also showed a better sensitivity, specificity and positive predictive value than FPG. The
pooled correlation coefficient (r) between PPG and HbA1c was 0.68 (P < 0.001, 95 % CI; 0.56–0.75) slightly higher
than pooled correlation coefficient of FPG (r = 0.61(P < 0.001, 95 % CI; 0.48–0.72)).
Conclusion: PPG has a closer association with HbA1c than FPG. Hence, PPG is better in predicting overall glycemic
control in the absence of HbA1c.
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Introduction
Glycemic control is the most important aspect in man-
agement of diabetes mellitus. It is a cornerstone in redu-
cing morbidity and mortality of the diseases [1, 2]. The
chronic hyperglycemia of diabetes is associated with long
term damage, dysfunction, and failure of various organs,
especially the eyes, kidneys, nerves, heart, and blood ves-
sels [3]. Many large randomized clinical trials and obser-
vational studies in type 1 and 2 diabetes have clearly
shown that achieving glycemic control or reducing
hyperglycemia significantly decrease the microvascular
and macrovascular complications of diabetes mellitus
(DM) [4–6].
Control of plasma glucose in patients with diabetes
can be assessed by measurement of glycated hemoglobin
(HbA1c), fasting plasma glucose (FPG), and postprandial
plasma glucose (PPG). However, still measurement of
HbA1c level remains the gold standard for assessment
of glycemic control at follow up [7]. The concentration
of HbA1c predicts diabetes complications because it re-
flects more harmful glycation sequelae of diabetes, such
as retinopathy and nephropathy, which are understood
to be due to harmful advanced glycation end products
[8–10]. Epidemiological and large randomized clinical
trial studies such as Diabetes Control and Complication
Trial (DCCT) and the United Kingdom Prospective Dia-
betes Study (UKPDS) indicated that HbA1c >7.0 % is as-
sociated with a significantly increased risk of both
microvascular and macrovascular complications, regard-
less of underlying treatment [4, 5, 11]. Since it reflects
the mean glycemic values in the previous 2–3 months,
HbA1c is an indicator for overall glucose exposure inte-
grating both fasting and postprandial hyperglycemia even
though their relative contribution is undefined [12, 13].
Nevertheless, HbA1c test is not available or very limited
in resource poor settings due to its high cost. In the ab-
sence of HbA1c test and high level of diabetic problems,
post-prandial and fasting plasma glucose estimation have
come into practice particularly in developing countries to
assess glycemic control [6]. A number of studies have
shown acceptable correlation between HbA1c levels and
FPG and PPG level [14]. However, circumstantial evidence
indicates that there is no consensus amongst professionals
whether FPG or PPG is a better predictor of glycemic con-
trol in resource poor settings when HbA1c is not available
[9, 15]. Nevertheless, for patients and health care pro-
viders, a clear understanding of the relationship between
different plasma glucose measurements and HbA1c is ne-
cessary for setting appropriate day-to-day plasma glucose
testing goals with the expectation of achieving specific
HbA1c targets.
The aim of this systematic review and meta-analysis
was therefore to summarize evidences on the signifi-
cance of fasting and postprandial plasma glucose, and
their correlation with HbA1c. This will help to identify
the better surrogate glycemic marker for achieving target
HbA1c level and for early detection of glycemic control
status.
Methods
Data source and search strategy
We followed standard guidelines for the systematic review
of diagnostic studies [16] and used the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
statement (Additional file 1: PRISMA) [17] as the template
for reporting the review. Using guidelines and check lists
of the standards we systematically identified and appraised
peer-reviewed original research reports on comparison of
correlations between fasting and 2-h postprandial plasma
glucose with HbA1c in assessment overall glycemic con-
trol. A literature search was done for published articles
using the online databases of EMBASE (www.embase.
com), PubMed (www.pubmed.gov), Cochrane library
(www.cochranelibrary.com/center), and google scholars
(scholar.google.com) from their inception to February
2015. Bibliographies of included studies and inter-
national and national guidelines on diabetes mellitus
management and diagnosis as well as unpublished
articles were hand-searched for additional relevant
studies. The databases were searched in January and
February 2015.
The main search terms used individually or in combina-
tions were: diabetes, hyperglycemia, type 1 diabetes or
type 2 diabetes, hyperglycemia; fasting, pre-prandial
hyperglycemia, basal hyperglycemia, Postprandial hyper-
glycemia, 2 h postprandial hyperglycemia, HbA1c or gly-
cated hemoglobin, Glycemic control, glucose monitoring,
diabetic control, glycemic target.
Study selection
We reviewed and examined relevant articles that com-
pared the correlation of fasting and 2- h postprandial
plasma glucose with HbA1c value for eligibility begin-
ning with titles and abstracts then followed by full text
review.
Eligibility criteria
The following inclusion criteria were applied: original
studies; articles published in English; reported response
rate ≥80 %; studies that compared the correlation of fast-
ing and 2–hour Postprandial plasma glucose values to
the standard HbA1c value, studies done in diabetic pa-
tients; studies that reported quality assurance methods.
Studies were excluded if compared fasting and 2–hour
Postprandial plasma glucose values with mean glucose
value, studies done in pregnant women; Primary studies
that focused on effect of various treatment on fasting or
postprandial plasma glucose or that aimed to determine
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the complication of fasting or postprandial plasma glu-
cose were excluded from both systematic review and
meta-analysis. Studies which did not report correlation
coefficient (r) were excluded from Meta-analysis. The
two investigators (EBK, KTK) assessed eligibility of all
articles meeting the inclusion criteria through full text
review. There was no any disagreement between the au-
thors for the eligibility of selected articles.
Data extraction /abstraction
Data extraction was performed by two independent re-
searchers (EBK, KTK) using pretested and standardized
abstraction form. Data were pulled out from each study
for the following variables: title; first author; year of pub-
lication; study design; type of diabetes; cutoff points for
fasting, postprandial plasma glucose and HbA1C; correl-
ation coefficient (r) of fasting and 2 h postprandial
plasma glucose with HbA1c; duration of diabetes; mean
age of patients, mean HbA1c value; treatment set up,
nutritional and other interventions; Methods of glucose
and HbA1C analysis were also considered. When there
was a disagreement in data abstraction, it was resolved
through consensus between the two investigators.
Definitions
Fasting and 2 h postprandial plasma glucose were
defined as value of plasma glucose measured after
overnight (8–12 h) fasting and after 2 h of meals re-
spectively [1]. Cut off point values were considered
as value which are used to classify the result of
given parameter as normal (good) and abnormal
(poor) [18]. HbA1c is a measure of the degree to
which hemoglobin is glycosylated in erythrocytes and
is expressed as a percentage of total hemoglobin
concentration [9].
Methodological quality assessment
Clearly described methods of patient selection and char-
acteristics of the included patients, use of predefined
good glycemic control cut off points for HbA1c, FBS
and PPBS, description on how the index tests (FPG, and
2hPPG) and the reference standard (HbA1c) were con-
ducted and interpreted, clear data collection methods
and procedures, reported quality assurance methods
(training of data collectors, pretesting, supervision, cali-
bration, standardization of meals) and reporting of lost
follow-up were considered as a study quality indicators.
Heterogeneity assessment
The presence of statistical heterogeneity was evaluated
using Cochran’s Q test (P < 0.10 reflected indicative of
statistically significant heterogeneity) and magnitude of
statistical heterogeneity between studies was assessed
using I2 (values of 25 %, 50 % and 75 % were considered
to represent low, medium and high heterogeneity re-
spectively) [19].
Data synthesis and statistical analysis
The descriptions of original studies were summarized
using Tables and forest plot. The MedCalc (1993–2015)
software was used for data entry and analysis. The ran-
dom effect model was used to estimate the pooled cor-
relation considering any heterogeneity inherent in the
meta-analysis. The estimated pooled correlation was pre-
sented with the 95 % confidence interval (CI). We also
performed robustness analysis to assess the impact each
study on the pooled result by removing one at a time
from the analysis for all studies.
Result
Identified studies
We identified 126 articles by the electronic search in
MEDLINE/PubMed, Google scholar, Cochrane central
Library and reference lists of included studies. Of the
total, 112 were excluded after reviewing titles, abstracts
and full text and applying the inclusion criteria. Fourteen
studies were included in systematic review. From these
14 articles, only 11 of them were incorporated in meta
analysis (Fig. 1). All of the included articles had per-
formed comparisons between fasting and postprandial
blood 166 glucose with HbA1c.
Characteristics of included studies
Publication dates ranged from 1997–2014 with more
publications done in 2014 (n = 3). Data from a total
of 4007 and 2403 diabetic patients were included in
this systematic review and meta-analysis, respectively.
The included articles had study population varied
from 50 (Gupta et al. 2014) to 1186 (Swetha et al.,
2014) and were conducted from 9 different countries.
Mean age of the study subjects ranged from 48.4 (Saiedul-
lah et al., 2013) to 62.4 years (Woerle et al., 2007) al-
though most were in between 55 and 60 (n = 7). As shown
in Table 1 below almost all of the included studies (n = 13)
used a cross-sectional study design. While eleven studies
were done in type 2 diabetic patients exclusively, the rest
3 studies included both type 1 and type 2 diabetic
patients.
Some of the studies (Schernthaner et al., 2010; Saeed,
2006; Monnier et al.,2003; Bonora et al., 2001) included
only patients who had not changed their treatment and
dietary habits while Schernthaner et al., (2010) and
Woerle et al., (2007) used unsatisfactory glycemic con-
trol (HbA1c > 7.5 % & 6.5 %, respectively) as their main
inclusion criteria. Majority of studies (n = 9) were done
on diabetic patients taking non-insulin oral anti diabetic
treatment. Only five of the included studies stated inter-
ventions they undertaken (4 food or diet and 1 intensive
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treatment) while the rest (n = 9) did not specify or car-
ried out any interventions (Table 1).
Plasma glucose and HbA1c measurements
In 86 % of the included studies plasma glucose was deter-
mined by glucose oxidase-peroxidase enzymatic method
in automated clinical chemistry analyzers. Two studies,
Woerle et al. (2007) and Schernthaner et al. (2010),
used glucose data measured by self-monitoring glu-
cose device. HbA1c was measured using ion exchange
high-performance liquid chromatographic techniques
in all included studies except two studies, Gupta et
al. (2014) and Datta et al., (2014), who used immuno-
turbidimetric methods. Six of the included studies
used two blood samples each for FPG and 2hPPG de-
termination taken before and after 2 h of breakfast,
respectively. The other five studies employed multiple
plasma glucose measurements per day before and
after each meal (breakfast, lunch and dinner) while
Saeed (2006) and Haddadihneshad et al. (2010) used
the average value of 3 separate plasma glucose mea-
surements done on different days. But Shrestha et al.
(2012) used the average of plasma glucose measured
for 15 consecutive days (Table 2).
Outcome measures and summary of findings
Most of the included studies (n = 11) calculated Pearson’s
correlation coefficient to measure the strength of asso-
ciation between FPG or PPG and HbA1c. From these,
seven studies found a better correlation between PPG
and HbA1c than FPG. In contrast to this, the other
three studies revealed a stronger correlation between
FPG and HbA1c than PPG. The remaining one study
found almost equal correlation coefficients for both
tests. The correlation coefficient (r) ranged from 0.20–
0.86 for PPG and from 0.28–0.84 for FPG. Both the
maximum(r = 0.86) and minimum (r = 0.20) values was
found in PPG. All studies reported a statistically sig-
nificant (p- value < 005) correlation between PPG or
FPG and HbA1c.
Alternatively, Woerle et al. (2007), Schernthaner et al.
(2010), Monnier et al.,(2003) employed a different approach
to estimate the relative contribution of FPG & PPG to the
overall glycemia. Woerle and his colleagues found that only
64 % patients achieving FPG targets of <100 mg/dl achieved
an HbA1c target of <7 % whereas 94 % of patients achiev-
ing the postprandial target of <140 mg/dl did. A decrease
in PPG was accounted for nearly twice as much as FPG
did for the decreases in HbA1c. On the other hand
Fig. 1 Flow diagram of search strategies
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Schernthaner et al. (2010) described the dependency
of relative contribution of FPG & PPG to the overall
glycemia by HbA1c values. The authors stated that
PPG play a major role in patients suffering from mild
or moderate hyperglycemia while FPG appears as a
main contributor to the overall diurnal hyperglycemia
in poorly controlled diabetic patients. Similar sugges-
tions were also made by Monnier and his co-authors.
Collectively, the data from these three studies indicated
that PPG contributes more than FPG to overall hypergly-
cemia as control of PPG was found essential either to de-
crease or to obtain HbA1c goals of <7.
Only four studies calculated the specificity, sensitivity
and positive predictive value of FPG and 2hPPG tests to
detect the change in HbA1c values in addition to Pear-
son’s correlation. Of these four studies, three of them
found better sensitivity, specificity and positive predict-
ive value for PPG than FPG (Table 2). This indicates that
PPG is more sensitive, more specific and has a higher
predictive value than FPG. However, these studies used a
different cut of value for both FPG and PPG. Datta et
al., (2014) also determined the measure of accuracy of
the two tests and found higher value for PPG (92 %)
than FPG (83 %) (Table 2).
Generally in all of the three approaches or methods,
PPG was found to be strongly correlated or to be a bet-
ter parameter in predicting or achieving target HbA1c
values than FPG. Summary of the results showed that
PPG has a better correlation with HbA1c, superior ac-
curacy (sensitivity and specificity) to predict HbA1c
values and greater contributions to achieve target
HbA1c values than FPG.
Meta analysis
Meta-analysis was done on eleven selected studies
listed in Table 3. All the studies included in meta-
analysis quantitatively measured the relationship be-
tween FPG and 2hPPG and the standard HbA1c
Table. 2 Sensitivity, specificity and positive predictive value (PPV) of fasting and postprandial plasma glucose tests in four studies
included in systematic review
Studies Citation Sensitivity (%) Specificity (%) PPV (%)
FPG PPG FPG PPG FPG PPG
Rosediani et al., 2006 [13] 81 75 58.3 80.6 70.6 82.5
Swetha et al., 2014 [6] 74 79 84 74 87 80
Datta et al., 2014 [23] 85 92 81 90 89 95
Avignon et al., 1997 [24] 69 73 85 92 62 76
Overall result PPG is more sensitive PPG is more specific PPG has higher predictive value
FPG fasting plasma glucose, PPG Postprandial plasma glucose, PPV Positive predictive value
Table. 1 Characteristics of studies included in systematic review and meta-analysis








Study design Study site
Saeed, 2006 [20] Type 2a 56 55.66 Oral antidiabetic 97 cross sectional Sudan
Haddadihneshad
et al., 2010




300 Cross sectional Iran
Rosediani et al., 2006 [13] Type 2 53.7 56.7 Oral antidiabetic 82 cross sectionalb Malaysia
Swetha et al., 2014 [6] Type 2 38.6 55.43 NS 1186 cross sectional India
Gupta et al., 2014 [22] Type 2 NS NS Oral antidiabetic 50 Cross sectional Italy
Datta et al.,2014 [23] type 1 & 2 53.3 51 Oral antidiabetic 120 cross sectional India
Avignon et al., 1997 [24] Type 2 36.3 40 - 78
(range)
Oral antidiabetic 66 cross sectionalb France
Bonora et al., 2001 [25] Type 2a 43.1 59.5 Oral antidiabetic 371 cross sectionalb Italy
Shrestha et al., 2012 [26] Type 2 53.3 58.9 Oral antidiabetic 60 cross sectionalb India
Azim et al., 2011 [27] type 1 & 2 35.0 51.8 NS 71 cross sectional Pakistan
Saiedullah et al., 2013 [28] Type 2 44.1 48.4 Oral antidiabetic 177 cross sectionb Bangladesh





Schernthaner et al., 2010 [30] Type 2 46.4 56.7 Oral antidiabetic 973 cross sectional Multi center
Monnier et al.,2003 [12] Type 2a 52.0 60.1 Oral antidiabetic 290 cross sectional France
a:constant diets and/or drugs were used for at least 3 months before the study; b:controlled or standardized meal before testing; NS not specified
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values using Pearson’s correlation coefficient (r value).
Seven of the studies included in meta-analysis found
better correlations between 2hPPG and HbA1c while
the remaining 3 studies reported better correlation
between FPG and target HbA1c values as shown in
Table 3. Based on meta-analysis of these 11 included
studies the pooled correlation coefficient was
0.61(95 % CI; 0.48–0.72) for FPG and 0.68 (95 % CI;
0.56–0.75) for 2hPPG using random effect model as
presented in Figs. 2 and 3. Forest plot for correlations
of FPG and 2hPPG with HbA1c is shown in Figs. 2
and 3, respectively. Forest plot for correlations of
FPG and 2hPPG with HbA1c is shown in Figs. 2 and
3, respectively. Size of the square is proportional to
the precision of the study-specific effect estimates,
and the bars indicate the corresponding 95 % CIs.
The diamond is placed on the summary correlation
coefficient of the observational studies, and the width
indicates the corresponding 95 % CI
Since the included studies used a different cut off points
for FPG and PPG, we didn’t perform meta analysis for
sensitivity, specificity and positive predictive value of FPG
and PPG (Table 3). The use of different cut off points for
defining good glycemic control affects the sensitivity, spe-
cificity and positive predictive values of FPG and PPG
tests.
Heterogeneity assessment
The 11 studies included in meta-analysis showed high het-
erogeneity according to Cochrane Q and I2 test statistic.
Q test, p < 0.001 and I2 test = 94.3 % was found for FPG.
Similarly Q test p < 0.001 and I2 test = 93.2 % was for
PPBS which are indicatives for using random effects
model. We also performed robustness analysis by revolv-
ing one article at a time. But each study did not bring sig-
nificance difference on the final pooled correlation
coefficient.
Discussion
Historically, glycemic control efforts have emphasized on
achievement of HbA1c and FPG targets [31]. Unfortu-
nately majority (more than two thirds) of patients in
therapeutic aims targeting for HbA1c and FPG has failed
to achieve their glycemic goals [1, 32]. On the other hand,
HbA1c has some important limitations and is a rather
complex measure of hyperglycemia. A large number of
medical condition such as the presence of hemoglobin
variants, malignancies, hemolytic anemia, and variety of
systemic conditions as well as various medications and
pregnancy are associated with alterations in the HbA1c
values and may provide unreliable information [33, 34].
Apart from these factors, HbA1c also neither captures
glucose fluctuations over short period of time nor provide
any information on glucose dynamics [18]. But these gly-
cemic variability are critical for safe and timely treatment
adjustment and clinical decision makings [35]. As a result,
there has been increasing interest in additional markers
for better glycemic control over shorter timeframes [18].
In this review we identified 14 articles that equated the
relationship between short term glucose measures, FPG
and 2 h PPG, and long term glycemic indicator HbA1c.
According to this review and meta-analysis a better correl-
ation was found between 2 h PPG and HbA1c than FPG
(pooled correlation (r) 0.67 Vs 0.61). This means that
Fig. 2 Forest plot of the 11 studies that quantitatively assessed the correlation between HbA1C and FPG represented by the random effect
model. Size of the square is proportional to the precision of the study-specific effect estimates, and the bars indicate the corresponding 95 % CIs.
The diamond is placed on the summary correlation coefficient of the observational studies, and the width indicates the corresponding 95 % CI
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patients who achieved 2 h PPG within the reference limit
will better accomplish target HbA1c values than patients
realized FPG within recommended range.
Some of the included studies indicated that PPG levels
made the highest contribution in the lower HbA1c quin-
tile (in good or fair HbA1c values whereas fasting hyper-
glycemia appeared as the main contributor to the overall
hyperglycemia in patients with poorly controlled disease
(HbA1c > 9 %). In other expression it means that de-
creases in PPG accounted for greater decrease in HbA1c
compared with decreases in FPG so that control of PPG
is an important consideration for achieving recom-
mended HbA1c goals <7 % than FPG. Three out of four
studies also found a better sensitivity, specificity, and
positive predictive value for PPG. This can be inter-
preted as when PPG is high or its control is poor it is
more likely to get high HbA1c above the recommended
range. Our review shad that in all the circumstances PPG
is either a better correlate or accurately predicts HbA1c
value or its contribution to the overall hyperglycemia is
greater than FPG signifying that control of postprandial
hyperglycemia is essential for achieving recommended
HbA1c goals.
Growing body of evidences have also shown a strong
association between PPG and cardiovascular risk and
outcomes [36], oxidative stress, carotid intimal thickness
Fig. 3 Forest plot of the 11 studies that quantitatively assessed the correlation between HbA1C and PPG represented by the random effect
model. Size of the square is proportional to the precision of the study-specific effect estimates, and the bars indicate the corresponding 95 % CIs.
The diamond is placed on the summary correlation coefficient of the observational studies, and the width indicates the corresponding 95 % CI
Table. 3 Characteristics of Studies included in meta-analysis
Studies Type of
DM
Study design Cut off points for good glycemic control (mg/dL) Correlation between HbA1c and
FPG PPG HbA1c (%) FPG PPG
Saeed, 2006 Type 2 cross sectional 120 160 7 % 0.60 0.20
Haddadihneshad et al., 2010 Type 1 & 2 cross sectional 120 160 ND 0.32 0.43
Rosediani et al., 2006 Type 2 cross sectional 110 145 7 % 0.58 0.60
Swetha et al., 2014 Type 2 cross sectional 130 180 7 % 0.74 0.76
Gupta et al., 2014 Type 2 cross sectional 120 140 6.5 % 0.68 0.62
Datta et al., 2014 Type 1 & 2 cross sectional 110 126 7 % 0.84 0.86
Avignon et al., 1997 Type 2 cross sectional 120 140 ≤7.0 % 0.62 0.81
Bonora et al., 2001 Type 2 cross sectional 120 160 7 % 0.48 0.48
Shrestha et al., 2012 Type 2 cross sectional 120 200 >6.5 % 0.45 0.63
Azim et al., 2011 Type 1 & 2 cross sectional 126 200 >6.5 % 0.28 0.44
Saiedullah et al., 2013 Type 2 cross section ND ND ND 0.81 0.77
DM diabetes mellitus, ND cut off value not defined, HbA1c glycated hemoglobin, FBS fasting plasma glucose, PPBS postprandial plasma glucose
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and endothelial dysfunction [37]. A recent diabetes com-
plications trial study concluded that PPG, but not FPG,
was an independent predictor of mortality and cardio-
vascular complications in diabetes [36, 38, 39]. It is also
plausible that humans spend half of their lives in post-
prandial states and thus, to achieve better long-term
metabolic control (HbA1c) and minimize the risk of
chronic diabetic complications, glucose monitoring in
postprandial state will be indispensable.
However, this review was also based on most data
collected from type 2 (n = 11) and few (n = 3) from
both type 1 and type 2 diabetic patients. Considering
the biochemical and pathological differences in the
two types, a distinct approach would be appropriate
to characterize these associations in type 1 diabetic
patients. Regarding day to day variations numerous
evidences suggested that several determination of glu-
cose over a period of several weeks would be better
indicator of glycemia and then better correlated with
HbA1c than single or few measurements in single
day. But in this review only three studies (Saeed,
2006; Haddadihneshad et al., 2010 and Shrestha et al.,
2012) used the average value of 3 or more separate
plasma glucose measurements done on different days.
All others were based on either glucose data gener-
ated on single day or single glucose measurement.
None of the included studies identified the separate
effect of age and sex on the association between these
different plasma glucose profiles and HbA1c values.
However Szoke et al. found that older people have more
postprandial hyperglycemia than younger people [40]. Fi-
nally significant heterogeneity was found in the pooled
correlation estimates of both FPG and PPG. Even though
we attempted to explain it through the random effect re-
gression model, many factors possibly contributing to this
residual heterogeneity could not be assessed because they
were not reported in most studies. For example, duration
of diabetes and type of treatments are likely to have an
important effect on correlation results. Finally it should
not be also ignored that methodological differences may
contribute to the study to study variation. It is suggested
that the multiple regression analysis used for studying the
relationship between A1C and glucose values at different
times is an unstable model when explanatory variables, i.e.,
the glucose values in this case, are inter correlated [41].
Limitation
Inclusion of different studies from different geographical
location, treatment group as well as from different meth-
odological approach would be problematic to end up
with particular inferences. Lack of uniform cut off points
for good glycemic control across the studies disallowed
us to pool the specificity and sensitivity of FPG and PPG
in predicting HbA1c values. And also due to incomplete
data on inclusion criteria, duration of diabetes, age
groups and others it was difficult to perform subgroup
analysis. Another constraint in this meta analysis could
arise from publication bias as studies that have negative
result are less likely to be published.
Conclusion
The result of our reviews showed that PPG strongly cor-
relate with HbA1c or contributes significantly to overall
glycemic control. This is in line with contemporary evi-
dence that showed strong relation between PPG and de-
velopment of diabetes complications. Consequently we
in a position to claim that special attention should be
given to monitoring and treating PPG until the ongoing
debate are resolved through large randomized control
trials. Hence monitoring of PPG will be more helpful to
achieve optimal glycemic control and prevent long term
diabetes complication than FPG alone in the absence of
HbA1c, especially in developing countries.
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